human blood coagulation factor viii
PolandDrugs containing this active substance
-
The medicinal product is used for the prevention and control of bleeding in patients with haemophilia A (congenital deficiency of coagulation factor VIII) and in patients with von Willebrand disease (VWD) when desmopressin treatment is ineffective or contraindicated. It may also be used in the treatment of acquired deficiency of human coagulation factor VIII.
Form: powder and solvent for solution for injection and infusion
Active substance Dosage human blood coagulation factor viii 500 j.m. human von willebrand factor 600 j.m. ATC: B02BD06
Manufacturer: Instituto Grifols S.A.
-
The medicine is used for the prevention and control of bleeding in patients with hemophilia A (factor VIII deficiency) and in patients with von Willebrand disease (when desmopressin treatment is ineffective or contraindicated). It may also be used in the treatment of acquired factor VIII deficiency.
Form: powder and solvent for solution for injection and infusion
Active substance Dosage human von willebrand factor 300 j.m. human blood coagulation factor viii 250 j.m. ATC: B02BD06
Manufacturer: Instituto Grifols S.A.
-
The medicinal product is used for the prevention and control of bleeding in patients with haemophilia A (deficiency of factor VIII) and in patients with von Willebrand disease (when desmopressin treatment is ineffective or contraindicated). It may also be used in the treatment of acquired factor VIII deficiency.
Form: powder and solvent for solution for injection and infusion
Active substance Dosage human blood coagulation factor viii 1000 j.m. human von willebrand factor 1200 j.m. ATC: B02BD06
Manufacturer: Instituto Grifols S.A.
-
The medicine is used for the prophylaxis and treatment of bleeding in patients with hemophilia A (congenital deficiency of factor VIII in the blood).
Form: solution for injection, powder and solvent for preparation of
Active substance Dosage human blood coagulation factor viii 250 IU ATC: B02BD04
Manufacturer: Bio Products Laboratory Limited
-
The medicine is used for the treatment and prevention of bleeding in people with haemophilia A (congenital deficiency of factor VIII in the blood).
Form: solution for injection, powder and solvent for preparation of
Active substance Dosage human blood coagulation factor viii 500 IU ATC: B02BD04
Manufacturer: Bio Products Laboratory Limited
-
The medicine is used to prevent and treat bleeding in people with hemophilia A (congenital deficiency of factor VIII in the blood).
Form: solution for injection, powder and solvent for preparation of
Active substance Dosage human blood coagulation factor viii 1000 IU ATC: B02BD04
Manufacturer: Bio Products Laboratory Limited